Optimization of checkpoint immunotherapy against lung cancer
Emerging clinical trials
Details on this Phase II, double blind, placebo controlled trial are available here.
Achieving Cures Together is tax exempt pursuant to IRC Section 501(c)(3). Contributions are deductible to the extent allowed by law.
